The patient's level of general health improvement depends on the initial level of damage to the central nervous system. Roughly speaking, if the damage is long-term and extensive, therapy results will be less vivid.
When making the decision to undergo CCSVI therapy and treatment, it must be remembered that endovascular intervention (just as in every surgical procedure) may entail the risk of postoperative complications.
It must be noted that all statements concerning the effectiveness of CCSVI therapy are largely based on a limited range of investigational data. This is due to the fact that CCSVI theory is still in an early stage of development. Nevertheless, the reference group to which detailed and long term investigation is applied is too small to conclude final and scientifically confirmed findings. This is especially relevant to the long term efficiency of the therapy, in particular regarding patients suffering from MS.
RIKS RELATED TO ANGIOPLASTY AND STENTS
About 1- 2% of people who have a stented artery or vein develop a blood clot at the stent site. The risk of blood clots is greatest during the first few months after the stent is placed in the artery or vein. Doctors will likely recommend that patients take aspirin and other anti-platelet drugs, such as clopidogrel, for at least 1 month or up to one year or more after having a stent procedure performed. These medicines inhibit thrombus formation.
The length of time patients need to take anti-platelet medicine depends on the type of stent implanted. Doctors may recommend lifelong treatment with aspirin.
For more detailed information concerning the angioplasty procedure, please refer to this website: Angioplasty and Vascular Stenting.